Showing results (1731-1740 of 1,842) with videos related to
Sort By:
Pageof 185
Lung Cancer (Amsterdam, Netherlands)|December 17, 2019
Independent prognostic value of ultra-sensitive quantification of tumor pre-treatment T790M subclones in EGFR mutated non-small cell lung cancer (NSCLC) treated by first/second generation TKI, depends on variant allele frequency (VAF): Results of the French cooperative thoracic intergroup (IFCT) biomarkers France projectMichèle Beau-Faller, Erwan Pencreach, Charlotte Leduc, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 13, 2017
Characteristics and Outcomes of Patients with Lung Cancer Harboring Multiple Molecular Alterations: Results from the IFCT Study Biomarkers FranceNicolas Guibert, Fabrice Barlesi, Renaud Descourt, et al.Biochemical Pharmacology|July 14, 2022
Treatment and prevention of pathological mitochondrial dysfunction in retinal degeneration and in photoreceptor injuryWalter H Moos, Douglas V Faller, Ioannis P Glavas, et al.Journal of Medicinal Chemistry|August 14, 2020
Target-Based Identification and Optimization of 5-Indazol-5-yl Pyridones as Toll-like Receptor 7 and 8 Antagonists Using a Biochemical TLR8 Antagonist Competition AssayThomas Knoepfel, Pierre Nimsgern, Sébastien Jacquier, et al.Der Pathologe|February 26, 2003
[Histopathological diagnosis of Barrett's mucosa and associated neoplasias. Results of a consensus conference of the Working Group for "Gastroenterological Pathology of the German Society for Pathology" on 22 September 2001]G Faller, R Berndt, F Borchard, et al.European Journal of Obstetrics, Gynecology, and Reproductive Biology|December 22, 2019
Impact of neoadjuvant chemotherapy cycles on survival of patients with advanced ovarian cancer: A French national multicenter study (FRANCOGYN)Lise Lecointre, Michel Velten, Massimo Lodi, et al.Molecular Cancer Therapeutics|March 14, 2012
High TUBB3 expression, an independent prognostic marker in patients with early non-small cell lung cancer treated by preoperative chemotherapy, is regulated by K-Ras signaling pathwayGuénaëlle Levallet, Emmanuel Bergot, Martine Antoine, et al.Blood Advances|August 2, 2023
Targeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 studyBradley Haverkos, Onder Alpdogan, Robert Baiocchi, et al.Oncotarget|December 24, 2016
MSH2/BRCA1 expression as a DNA-repair signature predicting survival in early-stage lung cancer patients from the IFCT-0002 Phase 3 TrialGuénaëlle Levallet, Fatéméh Dubois, Pierre Fouret, et al.Inorganic Chemistry|June 10, 2003
Speciation and unusual reactivity in PuO2+xSteven D Conradson, Bruce D Begg, David L Clark, et al.Pageof 185